The distribution of COPD in UK general practice using the new GOLD classification

John Haughney, Kevin Gruffydd-Jones, June Roberts, Amanda J Lee, Alison Hardwell, Lorcan McGarvey

Research output: Contribution to journalArticle

46 Citations (Scopus)

Abstract

The new Global Initiative for Chronic Obstructive Lung Disease (GOLD) 2011 document recommends a combined assessment of chronic obstructive pulmonary disease (COPD) based on current symptoms and future risk. A large database of primary-care COPD patients across the UK was used to determine COPD distribution and characteristics according to the new GOLD classification. 80 general practices provided patients with a Read code diagnosis of COPD. Electronic and hand searches of patient medical records were undertaken, optimising data capture. Data for 9219 COPD patients were collected. For the 6283 patients with both forced expiratory volume in 1 s (FEV1) and modified Medical Research Council scores (mean±sd age 69.2±10.6 years, body mass index 27.3±6.2 kg·m−2), GOLD 2011 group distributions were: A (low risk and fewer symptoms) 36.1%, B (low risk and more symptoms) 19.1%, C (high risk and fewer symptoms) 19.6% and D (high risk and more symptoms) 25.3%. This is in contrast with GOLD 2007 stage classification: I (mild) 17.1%, II (moderate) 52.2%, III (severe) 25.5% and IV (very severe) 5.2%. 20% of patients with FEV1 ≥50% predicted had more than two exacerbations in the previous 12 months. 70% of patients with FEV1 <50% pred had fewer than two exacerbations in the previous 12 months. This database, representative of UK primary-care COPD patients, identified greater proportions of patients in the mildest and most severe categories upon comparing 2011 versus 2007 GOLD classifications. Discordance between airflow limitation severity and exacerbation risk was observed.
Original languageEnglish
Pages (from-to)993-1002
Number of pages10
JournalEuropean Respiratory Journal
Volume43
Issue number4
Early online date31 Oct 2013
DOIs
Publication statusPublished - 1 Apr 2014

Fingerprint

General Practice
Chronic Obstructive Pulmonary Disease
Forced Expiratory Volume
Primary Health Care
Databases
Medical Records
Biomedical Research
Body Mass Index

Cite this

The distribution of COPD in UK general practice using the new GOLD classification. / Haughney, John; Gruffydd-Jones, Kevin; Roberts, June; Lee, Amanda J; Hardwell, Alison ; McGarvey, Lorcan.

In: European Respiratory Journal, Vol. 43, No. 4, 01.04.2014, p. 993-1002.

Research output: Contribution to journalArticle

Haughney, John ; Gruffydd-Jones, Kevin ; Roberts, June ; Lee, Amanda J ; Hardwell, Alison ; McGarvey, Lorcan. / The distribution of COPD in UK general practice using the new GOLD classification. In: European Respiratory Journal. 2014 ; Vol. 43, No. 4. pp. 993-1002.
@article{1d790329f83f4c97a380b04e7846c02a,
title = "The distribution of COPD in UK general practice using the new GOLD classification",
abstract = "The new Global Initiative for Chronic Obstructive Lung Disease (GOLD) 2011 document recommends a combined assessment of chronic obstructive pulmonary disease (COPD) based on current symptoms and future risk. A large database of primary-care COPD patients across the UK was used to determine COPD distribution and characteristics according to the new GOLD classification. 80 general practices provided patients with a Read code diagnosis of COPD. Electronic and hand searches of patient medical records were undertaken, optimising data capture. Data for 9219 COPD patients were collected. For the 6283 patients with both forced expiratory volume in 1 s (FEV1) and modified Medical Research Council scores (mean±sd age 69.2±10.6 years, body mass index 27.3±6.2 kg·m−2), GOLD 2011 group distributions were: A (low risk and fewer symptoms) 36.1{\%}, B (low risk and more symptoms) 19.1{\%}, C (high risk and fewer symptoms) 19.6{\%} and D (high risk and more symptoms) 25.3{\%}. This is in contrast with GOLD 2007 stage classification: I (mild) 17.1{\%}, II (moderate) 52.2{\%}, III (severe) 25.5{\%} and IV (very severe) 5.2{\%}. 20{\%} of patients with FEV1 ≥50{\%} predicted had more than two exacerbations in the previous 12 months. 70{\%} of patients with FEV1 <50{\%} pred had fewer than two exacerbations in the previous 12 months. This database, representative of UK primary-care COPD patients, identified greater proportions of patients in the mildest and most severe categories upon comparing 2011 versus 2007 GOLD classifications. Discordance between airflow limitation severity and exacerbation risk was observed.",
author = "John Haughney and Kevin Gruffydd-Jones and June Roberts and Lee, {Amanda J} and Alison Hardwell and Lorcan McGarvey",
year = "2014",
month = "4",
day = "1",
doi = "10.1183/09031936.00065013",
language = "English",
volume = "43",
pages = "993--1002",
journal = "European Respiratory Journal",
issn = "0903-1936",
publisher = "European Respiratory Society",
number = "4",

}

TY - JOUR

T1 - The distribution of COPD in UK general practice using the new GOLD classification

AU - Haughney, John

AU - Gruffydd-Jones, Kevin

AU - Roberts, June

AU - Lee, Amanda J

AU - Hardwell, Alison

AU - McGarvey, Lorcan

PY - 2014/4/1

Y1 - 2014/4/1

N2 - The new Global Initiative for Chronic Obstructive Lung Disease (GOLD) 2011 document recommends a combined assessment of chronic obstructive pulmonary disease (COPD) based on current symptoms and future risk. A large database of primary-care COPD patients across the UK was used to determine COPD distribution and characteristics according to the new GOLD classification. 80 general practices provided patients with a Read code diagnosis of COPD. Electronic and hand searches of patient medical records were undertaken, optimising data capture. Data for 9219 COPD patients were collected. For the 6283 patients with both forced expiratory volume in 1 s (FEV1) and modified Medical Research Council scores (mean±sd age 69.2±10.6 years, body mass index 27.3±6.2 kg·m−2), GOLD 2011 group distributions were: A (low risk and fewer symptoms) 36.1%, B (low risk and more symptoms) 19.1%, C (high risk and fewer symptoms) 19.6% and D (high risk and more symptoms) 25.3%. This is in contrast with GOLD 2007 stage classification: I (mild) 17.1%, II (moderate) 52.2%, III (severe) 25.5% and IV (very severe) 5.2%. 20% of patients with FEV1 ≥50% predicted had more than two exacerbations in the previous 12 months. 70% of patients with FEV1 <50% pred had fewer than two exacerbations in the previous 12 months. This database, representative of UK primary-care COPD patients, identified greater proportions of patients in the mildest and most severe categories upon comparing 2011 versus 2007 GOLD classifications. Discordance between airflow limitation severity and exacerbation risk was observed.

AB - The new Global Initiative for Chronic Obstructive Lung Disease (GOLD) 2011 document recommends a combined assessment of chronic obstructive pulmonary disease (COPD) based on current symptoms and future risk. A large database of primary-care COPD patients across the UK was used to determine COPD distribution and characteristics according to the new GOLD classification. 80 general practices provided patients with a Read code diagnosis of COPD. Electronic and hand searches of patient medical records were undertaken, optimising data capture. Data for 9219 COPD patients were collected. For the 6283 patients with both forced expiratory volume in 1 s (FEV1) and modified Medical Research Council scores (mean±sd age 69.2±10.6 years, body mass index 27.3±6.2 kg·m−2), GOLD 2011 group distributions were: A (low risk and fewer symptoms) 36.1%, B (low risk and more symptoms) 19.1%, C (high risk and fewer symptoms) 19.6% and D (high risk and more symptoms) 25.3%. This is in contrast with GOLD 2007 stage classification: I (mild) 17.1%, II (moderate) 52.2%, III (severe) 25.5% and IV (very severe) 5.2%. 20% of patients with FEV1 ≥50% predicted had more than two exacerbations in the previous 12 months. 70% of patients with FEV1 <50% pred had fewer than two exacerbations in the previous 12 months. This database, representative of UK primary-care COPD patients, identified greater proportions of patients in the mildest and most severe categories upon comparing 2011 versus 2007 GOLD classifications. Discordance between airflow limitation severity and exacerbation risk was observed.

U2 - 10.1183/09031936.00065013

DO - 10.1183/09031936.00065013

M3 - Article

VL - 43

SP - 993

EP - 1002

JO - European Respiratory Journal

JF - European Respiratory Journal

SN - 0903-1936

IS - 4

ER -